Royce & Associates LP Sells 233,726 Shares of Core Laboratories Inc. $CLB

Royce & Associates LP lessened its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 53.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 206,716 shares of the oil and gas company’s stock after selling 233,726 shares during the period. Royce & Associates LP’s holdings in Core Laboratories were worth $3,314,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. CWA Asset Management Group LLC acquired a new position in shares of Core Laboratories during the 4th quarter worth about $9,978,000. Pacific Ridge Capital Partners LLC acquired a new position in shares of Core Laboratories during the 3rd quarter worth about $525,000. UBS Group AG lifted its position in shares of Core Laboratories by 32.9% during the 4th quarter. UBS Group AG now owns 412,515 shares of the oil and gas company’s stock worth $6,613,000 after purchasing an additional 102,151 shares during the last quarter. Rhumbline Advisers lifted its position in shares of Core Laboratories by 1.0% during the 3rd quarter. Rhumbline Advisers now owns 141,662 shares of the oil and gas company’s stock worth $1,751,000 after purchasing an additional 1,441 shares during the last quarter. Finally, MQS Management LLC acquired a new position in shares of Core Laboratories during the 3rd quarter worth about $160,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Trading Down 2.1%

Shares of CLB opened at $13.65 on Friday. Core Laboratories Inc. has a 12-month low of $9.72 and a 12-month high of $20.36. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $629.27 million, a price-to-earnings ratio of 21.00, a P/E/G ratio of 2.69 and a beta of 0.99. The stock’s 50-day moving average price is $15.51 and its 200 day moving average price is $16.61.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The firm had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. During the same period in the previous year, the company posted $0.14 earnings per share. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. As a group, research analysts predict that Core Laboratories Inc. will post 0.56 earnings per share for the current year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Monday, May 11th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, May 11th. Core Laboratories’s payout ratio is currently 6.15%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CLB. Weiss Ratings cut Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. Wall Street Zen cut Core Laboratories from a “hold” rating to a “sell” rating in a research report on Monday, May 25th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $12.00.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.